申请人:Messadek Jallal
公开号:US20060233877A1
公开(公告)日:2006-10-19
The invention refers to the pharmaceutical combination including at least: a first compound selected among the group consisting of acetylsalicylic acid, salicylic acid, pharmaceutical derivatives thereof, and a second compound selected from the group consisting of lipidic betaines, betaines lipids, betaines of Formula (CH
3
)
3
N
+
(CH
2
)
n
COO
−
with n an integer from 1 to 5, pharmaceutically acceptable salts thereof, esters thereof, precursors thereof, and mixtures thereof, with the proviso that the second compound is different from the first compound and in an amount by weight at least three times the amount of first compound.
本发明所指的药物组合物至少包括:选自乙酰水杨酸、水杨酸及其药物衍生物的第一种化合物,以及选自脂质甜菜碱、甜菜碱脂质、式(CH-3)甜菜碱的第二种化合物。
3
)
3
N
+
(CH
2
)
n
COO
-
n 为 1 至 5 的整数、其药学上可接受的盐、其酯、其前体和其混合物,但第二种化合物不同于第一种化合物,其重量份量至少为第一种化合物的三倍。